The DOI matches its Crossref record; 202 of the 203 references it cites were found in a registry or an index; 26 of the 44 sources its claims cite were checked for support.
Probiotics for treating acute infectious diarrhoea
Open accessAbstract
BackgroundProbiotics may be effective in reducing the duration of acute infectious diarrhoea. ObjectivesTo assess the effects of probiotics in proven or presumed acute infectious diarrhoea. Search methodsWe searched the trials register of the Cochrane Infectious Diseases Group, MEDLINE, and Embase from inception to 17 December 2019, as well as the Cochrane Controlled Trials Register (Issue 12, 2019), in the Cochrane Library, and reference lists from studies and reviews.We included additional studies identified during external review. Selection criteriaRandomized controlled trials comparing a specified probiotic agent with a placebo or no probiotic in people with acute diarrhoea that is proven or presumed to be caused by an infectious agent. Data collection and analysisTwo review authors independently applied inclusion criteria, assessed risk of bias, and extracted data.Primary outcomes were measures of diarrhoea duration (diarrhoea lasting ≥ 48 hours; duration of diarrhoea).Secondary outcomes were number of people hospitalized in community studies, duration of hospitalization in inpatient studies, diarrhoea lasting ≥ 14 days, and adverse events. Main resultsWe included 82 studies with a total of 12,127 participants.These studies included 11,526 children (age < 18 years) and 412 adults (three studies recruited 189 adults and children but did not specify numbers in each age group).No cluster-randomized trials were included.Studies varied in the definitions used for "acute diarrhoea" and "end of the diarrhoeal illness" and in the probiotic(s) tested.A total of 53 trials were undertaken in countries where both child and adult mortality was low or very low, and 26 where either child or adult mortality was high.Probiotics for treating acute infectious diarrhoea (Review)
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
This Cochrane review of 82 randomized trials found that, in trials at low risk of bias, probiotics probably make little or no difference to whether acute infectious diarrhoea lasts ≥48 hours, and it is uncertain whether they shorten diarrhoea duration. The authors conclude that current evidence does not support using probiotics to treat acute infectious diarrhoea.
Key findings
- In low-risk-of-bias trials, probiotics vs control showed no difference in diarrhoea lasting ≥48 hours (RR 1.00, 95% CI 0.91 to 1.09; 2 trials, 1770 participants; moderate-certainty evidence).
- In low-risk-of-bias trials, mean duration of diarrhoea was 8.64 hours shorter with probiotics, but the 95% CI ranged from 29.4 hours shorter to 12.1 hours longer (6 trials, 3058 participants; very low-certainty evidence).
- Across all trials, pooled estimates suggested benefit (diarrhoea ≥48 hours RR 0.64, 95% CI 0.52 to 0.79; duration MD 21.3 hours shorter, 95% CI 15.7 to 26.9), but heterogeneity was very high and funnel plots suggested publication bias.
- Duration of hospitalization was shorter in probiotic groups (MD −18.03 hours, 95% CI −27.28 to −8.78; 24 trials, 4056 participants; I² = 96%), but no clear differences were detected for diarrhoea lasting ≥14 days or hospitalization in community studies; no serious adverse events were attributed to probiotics.
Methods
- Cochrane systematic review and meta-analysis of randomized controlled trials comparing a specified probiotic with placebo or no probiotic in adults and children with acute diarrhoea presumed or proven to be infectious; searches ran to 17 December 2019.
- Included 82 trials with 12,127 participants (11,526 children and 412 adults; 189 participants of unclear age group), with two reviewers independently assessing eligibility, risk of bias, and extracting data.
- Primary outcomes were diarrhoea lasting ≥48 hours and duration of diarrhoea; analyses used random-effects models because of marked heterogeneity, with GRADE certainty assessment, prespecified subgroup analyses, and sensitivity analyses limited to trials at low risk of bias.
Limitations
- The paper states that many included studies had high or unclear risk of bias, statistical heterogeneity was marked and largely unexplained, and funnel plots indicated publication bias.
- The paper notes that most participants were children, adult data were sparse, definitions of acute diarrhoea and recovery varied widely, and probiotic identity/viability was confirmed in only a few trials; adverse-event reporting was limited.
- The most robust analysis was restricted to only 2 trials for diarrhoea lasting ≥48 hours and 6 trials for duration, and GRADE certainty was moderate for the former and very low for the latter.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
26 of 44 cited sources checked · 19 supported · 2 flagged · accuracy not yet measured
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“The very marked heterogeneity between studies in this and other reviews argues against “core” properties shared by different probiotics that are effective against diarrhoea due to many different infectious agents and its occurrence in different populations and regions (Hill 2014).”
§ Probiotics for treating acute infectious diarrhoea > Authors' conclusions
What the sources say
- Disputedcites Hill 2014 sourceExperimental — accuracy not yet measured
The Core benefits section (p. 3) takes the opposite position: the panel says evidence supports ‘core’ benefits of certain probiotics and explicitly contrasts that view with the idea that every strain produces a different outcome. The Consensus statements (p. 3) also include infectious diarrhoea among the outcomes considered in support of general digestive-tract benefits. The paper does not use study heterogeneity to argue against shared properties. (LLM, conf=0.89)
Checked by a reasoning model — may be wrong.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Disputed
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Our findings do not support recommendations for the use of specific probiotics for acute infectious diarrhoea in children (Floch 2015; Guarino 2018; Sniffen 2018).”
§ Probiotics for treating acute infectious diarrhoea > Authors' conclusions
What the sources say
- Supportedcites Floch 2015 source
The citing authors’ statement about their own findings is not attributed to Floch et al.; the citation identifies the recommendations those findings challenge. The paper’s recommendations table (Additional information; page unavailable) lists specific probiotics for treating infectious diarrhoea in children, including LGG and Saccharomyces boulardii. (LLM, conf=0.91)
- Supportedcites Guarino 2018 source
The citing authors’ statement about their own findings is not attributed to Guarino 2018; the citation identifies a source of recommendations for specific probiotics. In Results > Active Treatment of Diarrhea, the paper says selected probiotic strains can be considered for children with acute gastroenteritis as an adjunct to oral rehydration solution. (LLM, conf=0.90)
- Disputedcites Sniffen 2018 sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) says the opposite: it finds strong evidence of efficacy for several specific probiotics in treating pediatric acute diarrhea, and moderate evidence for another formulation. The Results section also reports that S. boulardii reduced diarrhea duration in children. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In children from middle‐ and high‐income countries, probiotics reduced diarrhoea duration by 14% (95% CI 3.8% to 24.2%) and stool frequency on day two by 13.1% (95% CI 0.8% to 25.3%; Applegate 2013).”
§ Probiotics for treating acute infectious diarrhoea > Background > Why it is important to do this review
What the sources say
- Supportedcites Applegate 2013 source
The Results report that probiotics reduced stool frequency on day two of treatment by 13.1% (95% CI 0.8%–25.3%). The Discussion says the review combined studies from low- and middle-income countries with studies from high-income countries, consistent with the citing sentence’s population description. (LLM, conf=0.90)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, due to substantive heterogeneity of effect size between studies, evidence was insufficient to show a specific probiotic regimen as more effective than another (Allen 2010).”
§ Probiotics for treating acute infectious diarrhoea > Background > Why it is important to do this review
What the sources say
- Supportedcites Allen 2010 source
The Discussion (page unavailable) says that subgroup analyses did not explain the between-study heterogeneity and found no important differences in effect by probiotic strain, number of strains, viability, or dose. This supports the claim that the review could not identify one probiotic regimen as more effective than another. (LLM, conf=0.91)
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In children from middle‐ and high‐income countries, probiotics reduced diarrhoea duration by 14% (95% CI 3.8% to 24.2%) and stool frequency on day two by 13.1% (95% CI 0.8% to 25.3%; Applegate 2013).”
§ Probiotics for treating acute infectious diarrhoea > Background > Why it is important to do this review
What the sources say
- Supportedcites Applegate 2013 source
The Results report a 14.0% reduction in diarrhea duration (95% CI 3.8%–24.2%) and a 13.1% reduction in stool frequency on day two (95% CI 0.8%–25.3%). Table 2 lists the countries contributing to the diarrhea-duration estimate, and the Discussion says the review included studies from both lower- and middle-income countries and high-income countries. (LLM, conf=0.93)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Findings from the previous version of this Cochrane Review show that when probiotics were used, the mean duration of diarrhoea was shorter, and fewer children had diarrhoea lasting four days or longer.”
§ Probiotics for treating acute infectious diarrhoea > Background > Why it is important to do this review
What the sources say
- Supportedcites Allen 2010 source
The review’s Main results (page not provided) report a risk ratio of 0.41 for diarrhoea lasting four days or longer with probiotics, indicating fewer such cases. They also report a shorter mean duration of diarrhoea. The cited review is the previous version referred to in the citing sentence. (LLM, conf=0.92)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“In both meta‐analyses, evidence was insufficient to support a specific strain or regimen.”
§ Probiotics for treating acute infectious diarrhoea > Background > Why it is important to do this review
What the sources say
- Not checked — no full text of the sourcecites Salari 2012 source
- Supportedcites Applegate 2013 source
The Discussion (page unavailable) says the review could assess only LGG separately, found no significant strain-specific effect, and could not separate probiotic mixtures to evaluate individual strains or doses. The evidence table also notes differing doses and treatment durations and says there were not enough data to make a statement about each strain. This supports the conclusion that the evidence did not establish a specific strain or regimen. (LLM, conf=0.88)
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“However, in spite of this increased evidence base, recent systematic reviews have not identified a specific probiotic preparation for use in clinical practice.”
§ Probiotics for treating acute infectious diarrhoea > Background > Why it is important to do this review
What the sources say
- Not checked — no full text of the sourcecites Salari 2012 source
- Supportedcites Applegate 2013 source
The Discussion reports that this review could assess a pooled effect for only one individual strain, LGG, and that result was not significant. It could not separate probiotic mixtures by strain or dose, supporting the claim that the review did not identify a specific preparation for clinical use. (LLM, conf=0.88)
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesEvery source the paper cites for this claim was checked and supports it.
In the paper
“Findings from the previous version of this Cochrane Review show that when probiotics were used, the mean duration of diarrhoea was shorter, and fewer children had diarrhoea lasting four days or longer.”
§ Probiotics for treating acute infectious diarrhoea > Background > Why it is important to do this review
What the sources say
- Supportedcites Allen 2010 source
The Main results and Effects of interventions sections report that probiotics shortened mean diarrhoea duration and reduced the risk of diarrhoea lasting at least four days. The review’s History section says the 2010 update did not change its conclusions, supporting the reference to the previous version. (LLM, conf=0.92)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Of note, a recent large, well‐conducted trial of L rhamnosus GG in children in the USA did not observe a probiotic effect (Schnadower 2018).”
§ Probiotics for treating acute infectious diarrhoea > Discussion > Certainty of the evidence
What the sources say
- Supportedcites Schnadower 2018 source
The Methods (Trial Design and Oversight; page not provided) describe a randomized, double-blind trial at 10 US pediatric emergency departments. The Discussion (page not provided) reports that, among 971 preschool children with acute gastroenteritis, L. rhamnosus GG produced no better outcomes than placebo. This supports the citing sentence’s description of a large US trial that did not observe a probiotic benefit. (LLM, conf=0.94)
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- Supported
- It may state two separate claims as one. 65
- Probably not a substantial claim. 19
- The quote only partly states this claim. 1
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A notable finding was that two recently conducted large trials undertaken in children did not show a probiotic effect for the number of children with diarrhoea lasting ≥ 48 hours (Analysis 1.1) or for mean duration of diarrhoea (Analysis 1.2; Freedman 2018a; Schnadower 2018).”
§ Probiotics for treating acute infectious diarrhoea > Results > Effects of interventions
What the sources say
- Not matchedcites Freedman 2018a
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Partly supportedcites Schnadower 2018 sourceExperimental — accuracy not yet measured
The Results > Secondary Outcomes section reports no significant difference in diarrhea duration between the probiotic and placebo groups. The Abstract > Results gives median durations, not mean durations. Our copy does not report a comparison of the number of children whose diarrhea lasted at least 48 hours; its 48-hour subgroup concerns symptoms before treatment. (LLM, conf=0.85)
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Not matched
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Finally, two recent studies each recruited a large number of participants, potentially making a significant contribution to the evidence base (Freedman 2018a; Schnadower 2018).”
§ Probiotics for treating acute infectious diarrhoea > Background > Why it is important to do this review
What the sources say
- Not matchedcites Freedman 2018a
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Supportedcites Schnadower 2018 source
The Results (Participants and Adherence to Trial Intervention; page not provided) report that 971 participants were randomized, supporting the claim that the Schnadower study recruited a large number. The Discussion also describes its large sample and explains how its findings differ from earlier, smaller trials. This verdict concerns Schnadower 2018 only, not the other study cited in the sentence. (LLM, conf=0.93)
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Not matched
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Two review authors independently assessed the risk of bias for each trial using the Cochrane ’Risk of bias’ assessment tool (Higgins 2012).”
§ Probiotics for treating acute infectious diarrhoea > Methods > Data collection and analysis
What the sources say
- Could not verifycites Higgins 2012 sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) identifies this paper’s subject as inconsistency in network meta-analysis, not the Cochrane Risk of Bias tool. Searches for the tool and for independent trial-level risk-of-bias assessment found no passage in our copy that identifies the tool or describes the cited assessment procedure. (LLM, conf=0.77)
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Schnadower 2018 reported similar rates of adverse events in the two groups, except that wheezing was more common in children receiving L rhamnosus GG than in controls (5/472 versus 0/479 children; P = 0.03; borderline statistical significance in view of multiple comparisons); SAEs occurred in a similar number of children in each group.”
§ Probiotics for treating acute infectious diarrhoea > Results > Effects of interventions
What the sources say
- Partly supportedcites Schnadower 2018 sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The identity and viability of probiotic organisms were evaluated by bacteriology and molecular methods in seven studies (Freedman 2015; Freedman 2018a; Hong Chau 2018; Mao 2008; Rosenfeldt 2002a; Rosenfeldt 2002b; Schnadower 2018), and were evaluated independently of the study team in two of these studies (Freedman 2015; Schnadower 2018).”
§ Probiotics for treating acute infectious diarrhoea > Results > Effects of interventions
What the sources say
- Not checked — no full text of the sourcecites Freedman 2015 source
- Not matchedcites Freedman 2018a
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Partly supportedcites Schnadower 2018 sourceExperimental — accuracy not yet measured
The Methods section (“Testing of Stool Samples and L. rhamnosus GG Testing”; page not provided) says the trial’s probiotic capsules were independently tested for contaminants and viability. The Results section reports colony-forming-unit measurements. Our copy does not say that molecular methods were used to verify the probiotic’s identity; its PCR testing concerned stool pathogens. This paper also does not establish the citing sentence’s totals of seven studies and two independently evaluated studies. (LLM, conf=0.85)
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
Every source the paper cites for this claim was checked and supports it.
In the paper
“The Lactobacillus casei group comprises the closely related species L casei, L paracasei, and L rhamnosus, including L rhamnosus GG, and it is difficult to differentiate between these species (Hill 2018).”
§ Probiotics for treating acute infectious diarrhoea > Results > Effects of interventions
What the sources say
- Supportedcites Hill 2018 source
The Introduction identifies L. casei, L. paracasei, and L. rhamnosus as closely related members of the group and names L. rhamnosus GG as a member. “A Brief Taxonomic History” describes distinguishing these species as important and their taxonomy as convoluted and challenging, supporting the difficulty of differentiation. (LLM, conf=0.91)
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Fifty studies reported that no adverse events (AEs) were attributed to the probiotic(s), and two studies stated that no serious AEs (SAEs) were attributed to the probiotic (Phavichitr 2013; Simadibrata 2013).”
§ Probiotics for treating acute infectious diarrhoea > Results > Effects of interventions
What the sources say
- Not matchedcites Phavichitr 2013
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Supportedcites Simadibrata 2013 source
The Discussion (page unavailable) states that no serious adverse event was found in Simadibrata’s study. This supports citing it as one of the two studies reporting no serious adverse events; the count of fifty studies is not attributed to this individual trial. (LLM, conf=0.91)
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Not matched
Every source the paper cites for this claim was checked and supports it.
In the paper
“A systematic review of L reuteri DSM 17938 for treating acute gastroenteritis in children reported marked statistical heterogeneity and very low certainty of evidence for both duration of diarrhoea and duration of hospitalization (Patro‐Gołab 2019).”
§ Probiotics for treating acute infectious diarrhoea > Discussion > Agreements and disagreements with other studies or reviews
What the sources say
- Supportedcites Patro‐Gołab 2019 source
The Results (§3.2) report high heterogeneity for both diarrhoea duration (I² = 72%) and hospitalization duration (I² = 83%). The Discussion (§4.1) rates the evidence for each outcome as very low certainty. (LLM, conf=0.95)
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“A recent systematic review and network meta‐analysis of interventions for acute diarrhoea in children reported high statistical heterogeneity for duration of diarrhoea for L rhamnosus GG, S boulardii, and other probiotics grouped together versus standard treatment and certainty of evidence was graded as low or very low (Florez 2018).”
§ Probiotics for treating acute infectious diarrhoea > Discussion > Agreements and disagreements with other studies or reviews
What the sources say
- Supportedcites Florez 2018 source
Split into 2 atoms — 2 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“A recent systematic review that summarised trials of S boulardii in children with rotavirus diarrhoea (n = 548 children; five RCTs) reported a modest reduction in diarrhoea duration (MD –0.57 days; 95% CI –0.83 to –0.30) with consistency in findings (I2 = 0%) and moderate certainty evidence (Padayachee 2019).”
§ Probiotics for treating acute infectious diarrhoea > Discussion > Agreements and disagreements with other studies or reviews
What the sources say
- Could not verifycites Padayachee 2019 sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 2 unverifiable. Expand the claim to see per-atom verdicts.
Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Could not verify
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We included 82 studies with a total of 12,127 participants.”
§ Probiotics for treating acute infectious diarrhoea > Abstract > Main results
Strength:plain· not yet calibratedn = 12,127Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one. The quote only partly states this claim.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Heterogeneity also was not explained by types of participants (age, nutritional/socioeconomic status captured by mortality stratum, region of the world where studies were undertaken), diarrhoea in children caused by rotavirus, exposure to antibiotics, and the few studies of children who were also treated with zinc.”
§ Probiotics for treating acute infectious diarrhoea > Abstract > Main results
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These included analyses limited to the probiotics Lactobacillus rhamnosus GG and Saccharomyces boulardii.”
§ Probiotics for treating acute infectious diarrhoea > Abstract > Main results
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“A total of 53 trials were undertaken in countries where both child and adult mortality was low or very low, and 26 where either child or adult mortality was high.”
§ Probiotics for treating acute infectious diarrhoea > Abstract > Main results
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Effect size was similar and marked heterogeneity persisted in pre‐specified subgroup analyses of the primary outcomes that included all studies.”
§ Probiotics for treating acute infectious diarrhoea > Abstract > Main results
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“No cluster‐randomized trials were included.”
§ Probiotics for treating acute infectious diarrhoea > Abstract > Main results
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In addition, there were no clear differences in effect size for the primary outcomes in post hoc analyses according to decade of publication of studies and whether or not trials had been registered.”
§ Probiotics for treating acute infectious diarrhoea > Abstract > Main results
Strength:boosted· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Studies varied in the definitions used for “acute diarrhoea” and “end of the diarrhoeal illness” and in the probiotic(s) tested.”
§ Probiotics for treating acute infectious diarrhoea > Abstract > Main results
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Forty‐one (50.0%) studies were considered low risk for generation of the allocation sequence, 12 (14.6%) for concealment of allocation, 36 (43.9%) for blinding of participants and personnel, 30 (36.6%) for blinding of outcome assessment, 65 (79.3%) for loss to follow‐up, and 71 (86.6%) for selective reporting (Figure).”
§ Probiotics for treating acute infectious diarrhoea > Results > Risk of bias in included studies
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In total, 82 studies met the inclusion criteria (Characteristics of included studies).”
- Also stated in: § Summary of main results · plain
“This review included 82 studies with a total of 12,127 participants.”
§ Probiotics for treating acute infectious diarrhoea > Results > Description of studies
Strength:plain· not yet calibratedn = 12,127Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
- Also stated in: § Summary of main results · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These studies included 11,526 children (age < 18 years) and 412 adults (three studies recruited 189 adults and children but did not specify numbers in each age group).”
§ Probiotics for treating acute infectious diarrhoea > Abstract > Main results
Strength:plain· not yet calibratedn = 11,526Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The 82 selected studies recruited a total of 12,127 participants, including 11,526 children (age < 18 years) and 412 adults.”
§ Probiotics for treating acute infectious diarrhoea > Results > Description of studies
Strength:plain· not yet calibratedn = 12,127Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In six trials (433 participants) of Lactobacillus reuteri, there was consistency amongst findings (I² = 0%)”
§ Probiotics for treating acute infectious diarrhoea > Abstract > Main results
Strength:plain· not yet calibratedn = 433Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Effect size was similar in the sensitivity analysis and marked heterogeneity persisted.”
§ Probiotics for treating acute infectious diarrhoea > Abstract > Main results
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In seven trials (2333 participants) of acute diarrhoea in the community, probiotics did not reduce the risk of hospitalization (RR 1.21, 95% CI 0.86 to 1.69) with consistency in findings between studies (I² = 0%; Analysis 2.1).”
§ Probiotics for treating acute infectious diarrhoea > Results > Effects of interventions
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The effect estimate for probiotics on the duration of diarrhoea in children treated with zinc was similar to that in the main analysis, and marked statistical heterogeneity persisted (Analysis 10.1).”
§ Probiotics for treating acute infectious diarrhoea > Results > Effects of interventions
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For both diarrhoea lasting ≥ 48 hours and mean duration of diarrhoea, effect estimates were similar in studies where participants may have been exposed to antibiotics before recruitment and marked statistical heterogeneity between studies persisted (Analysis 9.1; Analysis 9.2).”
§ Probiotics for treating acute infectious diarrhoea > Results > Effects of interventions
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, there were no clear differences in effect sizes in these analyses, and heterogeneity persisted.”
§ Probiotics for treating acute infectious diarrhoea > Discussion > Certainty of the evidence
Load-bearingStrength:boosted· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“When analysis was restricted to studies where all indicators of risk of bias were low, there was no heterogeneity with consistent estimates of null effect in the two large studies meeting these criteria for number of participants with diarrhoea lasting ≥ 48 hours between study arms (RR 1.00, 95% CI 0.91 to 1.09; I² = 0%; two trials, 1770 participants; Analysis 11.1: subgroup 7).”
§ Probiotics for treating acute infectious diarrhoea > Results > Effects of interventions
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Similarly, for trials reporting mean duration of diarrhoea that were at low risk of bias for all six indices of study quality, no difference was demonstrated between intervention and control (MD 8.6 hours less, 95% CI 29.4 less to 12.1 hours more; 6 trials, 3058 participants). Heterogeneity persisted (I² = 97%; Analysis 11.2: subgroup 7).”
§ Probiotics for treating acute infectious diarrhoea > Results > Effects of interventions
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In nine trials (2928 participants), probiotics did not reduce the risk of diarrhoea lasting ≥ 14 days (RR 0.49, 95% CI 0.16 to 1.53) with heterogeneity in findings between studies (I² = 60%; Analysis 2.3).”
§ Probiotics for treating acute infectious diarrhoea > Results > Effects of interventions
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The remaining 17 studies did not report on adverse events.”
§ Probiotics for treating acute infectious diarrhoea > Results > Effects of interventions
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For this diarrhoeal pathogen, the effects of probiotics were similar to those in the main analyses, but again with marked statistical heterogeneity and risk of bias in many studies.”
§ Probiotics for treating acute infectious diarrhoea > Discussion > Certainty of the evidence
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Although most studies reported absence of adverse events due to probiotics, few studies provided a description of the methods used for detecting and classifying adverse events and few reported specific data on adverse events.”
§ Probiotics for treating acute infectious diarrhoea > Discussion > Overall completeness and applicability of evidence
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Effect sizes were similar and heterogeneity persisted in our pre‐planned subgroup analyses according to probiotic strain, diarrhoea caused by rotavirus, age, severity of illness, country mortality stratum or region, exposure to antibiotics, treatment with zinc in children, and risk of bias.”
§ Probiotics for treating acute infectious diarrhoea > Discussion > Overall completeness and applicability of evidence
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was great variability in the methodological quality of trials, but this did not appear to have contributed to heterogeneity.”
§ Probiotics for treating acute infectious diarrhoea > Discussion > Certainty of the evidence
Strength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The funnel plots are suggestive of publication bias for diarrhoea lasting ≥ 48 hours (Figure; Habord test; t = ‐4.57, P < 0.001) and possibly also mean duration of diarrhoea (Figure; Egger’s test; t = ‐3.33, P = 0.002).”
§ Probiotics for treating acute infectious diarrhoea > Results > Effects of interventions
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“However, most study participants were children, and available data for adults are sparse.”
§ Probiotics for treating acute infectious diarrhoea > Discussion > Overall completeness and applicability of evidence
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Heterogeneity was not resolved in sensitivity analysis according to individual parameters of risk of bias nor in subgroup analysis of trials where risk of bias for all six parameters was low.”
§ Probiotics for treating acute infectious diarrhoea > Discussion > Certainty of the evidence
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For children younger than five years, the effect estimate for diarrhoea lasting ≥ 48 hours was lower than in the main analysis (26 studies, 5033 children; RR 0.72, 95% CI 0.59 to 0.88) and marked statistical heterogeneity persisted (I² = 97%; Analysis 5.1: subgroup 1).”
§ Probiotics for treating acute infectious diarrhoea > Results > Effects of interventions
Strength:plain· not yet calibratedn = 5,033Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Also great variability in reported outcomes is evident, which limited data available for meta‐analysis for the primary outcomes.”
§ Probiotics for treating acute infectious diarrhoea > Discussion > Overall completeness and applicability of evidence
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Fifteen studies were registered in a trial database. For both primary outcomes, effect estimates were similar to the main analysis in these studies, and marked statistical heterogeneity persisted (Analysis 13.1; Analysis 13.2).”
§ Probiotics for treating acute infectious diarrhoea > Results > Effects of interventions
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Diarrhoea lasting ≥ 48 hours was reported in 21 studies (2354 participants) of participants who required admission and therefore were likely to have more severe illness. The effect estimate in these trials (RR 0.62, 95% CI 0.52 to 0.74) was similar to all studies, and marked heterogeneity in findings persisted (I² = 75%; Analysis 6.1).”
§ Probiotics for treating acute infectious diarrhoea > Results > Effects of interventions
Strength:plain· not yet calibratedn = 2,354Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In fewer studies, the effect estimate for L reuteri in reducing the duration of diarrhoea was similar to that in the main analysis but with less heterogeneity across studies (6 studies/433 participants; MD 22.8 hours, 95% CI 13.7 to 32.0; I² = 48%; Analysis 3.2: subgroup 3).”
§ Probiotics for treating acute infectious diarrhoea > Results > Effects of interventions
Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In 20 studies (1414 participants, all of whom were children), the reduction in duration of diarrhoea was similar to that in the main analysis, and marked statistical heterogeneity between studies persisted (MD 22.1 hours, 95% CI 14.2 to 29.9; I² = 84%; Analysis 4.1).”
§ Probiotics for treating acute infectious diarrhoea > Results > Effects of interventions
Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Pooled estimates of probiotic effect for these strains were similar to our overall findings, and statistical heterogeneity persisted for the first two strains.”
§ Probiotics for treating acute infectious diarrhoea > Discussion > Certainty of the evidence
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The effect estimate for diarrhoea lasting ≥ 48 hours among participants taking S boulardii was similar to the main analysis but was not statistically significant and findings show marked heterogeneity (RR 0.70, 95% CI 0.37 to 1.33; 9 studies, 1823 participants; I² = 99%; Analysis 3.1: subgroup 2).”
§ Probiotics for treating acute infectious diarrhoea > Results > Effects of interventions
Strength:plain· not yet calibratedn = 1,823Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Trials that evaluated L reuteri had less heterogeneity but risk of bias was present in all included studies.”
§ Probiotics for treating acute infectious diarrhoea > Discussion > Certainty of the evidence
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Although there was greater consistency among trials of adults (I² = 0%), only a few of these trials were included in this analysis and risk of bias was present in many.”
§ Probiotics for treating acute infectious diarrhoea > Discussion > Certainty of the evidence
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Mean duration of diarrhoea was reported in 36 inpatient studies (5071 participants) and in 8 outpatient studies (828 participants). The effect estimate was similar in these two groups, and marked heterogeneity was present in both analyses (I² = 97% and 94%, respectively; Analysis 6.2).”
§ Probiotics for treating acute infectious diarrhoea > Results > Effects of interventions
Strength:plain· not yet calibratedn = 5,071Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The reduction in duration of diarrhoea was similar to that in the main analysis, and marked statistical heterogeneity persisted (MD 24.6 hours, 95% CI 14.0 to 35.3; 11 studies, 1617 participants; I² = 89%; Analysis 3.2: subgroup 2).”
§ Probiotics for treating acute infectious diarrhoea > Results > Effects of interventions
Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In 24 inpatient trials (4056 participants), duration of hospitalization was reduced in the probiotic arm (MD 18.0 hours, 95% CI 8.8 to 27.3) but with marked statistical heterogeneity (I² = 95%; Analysis 2.2).”
§ Probiotics for treating acute infectious diarrhoea > Results > Effects of interventions
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Effect estimates were also similar when studies were grouped according to geographical region. Statistical heterogeneity persisted in these analyses with the exception of studies done in the Eur‐A region (Analysis 8.1: subgroup 3; I² = 27%).”
§ Probiotics for treating acute infectious diarrhoea > Results > Effects of interventions
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Among all trials included in this review, there was evidence of publication bias in trials reporting numbers of participants with diarrhoea lasting 48 hours or longer, with a greater number of smaller studies reporting a positive effect of probiotics (Figure).”
§ Probiotics for treating acute infectious diarrhoea > Discussion > Certainty of the evidence
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The effect estimate for diarrhoea lasting ≥ 48 hours was similar according to decade of publication (Analysis 12.1), and the difference between groups was of borderline statistical significance in the most recent studies (from 2010; 15 trials/3972 participants; RR 0.78, 95% CI 0.63 to 0.98; Analysis 12.1; subgroup 4).”
§ Probiotics for treating acute infectious diarrhoea > Results > Effects of interventions
Strength:plain· not yet calibratedn = 3,972Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In keeping with clinical management, diarrhoea aetiology was determined in only a minority of studies and meta‐analysis was possible only for rotavirus diarrhoea.”
§ Probiotics for treating acute infectious diarrhoea > Discussion > Certainty of the evidence
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in fewer studies of adults (≥ 18 years; 5 studies, 393 participants), probiotics reduced the RR of diarrhoea lasting ≥ 48 hours to a lesser degree than in the main analysis but with consistency between studies (RR 0.62, 95% CI 0.54 to 0.71; I² = 0%; Analysis 5.1: subgroup 2).”
§ Probiotics for treating acute infectious diarrhoea > Results > Effects of interventions
Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Analysis of these trials has changed our conclusion as they do not provide evidence of probiotic efficacy.”
§ Probiotics for treating acute infectious diarrhoea > Discussion > Agreements and disagreements with other studies or reviews
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Heterogeneity persisted in these analyses with the exception of studies done in the Eur‐A region”
§ Probiotics for treating acute infectious diarrhoea > Discussion > Certainty of the evidence
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Marked statistical heterogeneity and presence of risk of bias were also evident in studies that included people exposed to antibiotics and in the few studies of children treated with zinc.”
§ Probiotics for treating acute infectious diarrhoea > Discussion > Certainty of the evidence
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In analysis limited to trials evaluating the same probiotic strain, there was marked heterogeneity in findings and risk of bias in many of the included trials.”
§ Probiotics for treating acute infectious diarrhoea > Authors' conclusions
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Two review authors independently reviewed the titles of articles and, when available, abstracts generated by the search to identify potentially relevant studies.”
§ Probiotics for treating acute infectious diarrhoea > Methods > Data collection and analysis
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“To maximize the use of available data, we included participants of all ages and non‐blinded (open) studies; however, to keep results as robust as possible, we did not include quasi‐randomized and unpublished studies.”
§ Probiotics for treating acute infectious diarrhoea > Methods > Criteria for considering studies for this review
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Eligibility was assessed independently by these two people using a standard form and based on the information presented in the article.”
§ Probiotics for treating acute infectious diarrhoea > Methods > Data collection and analysis
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Two review authors independently extracted data using standard forms and compared the results.”
§ Probiotics for treating acute infectious diarrhoea > Methods > Data collection and analysis
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Two review authors independently applied inclusion criteria, assessed risk of bias, and extracted data.”
§ Probiotics for treating acute infectious diarrhoea > Abstract > Data collection and analysis
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“This analysis is based on large trials with low risk of bias.”
§ Probiotics for treating acute infectious diarrhoea > Abstract > Authors' conclusions
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Trial reports were scrutinized to ensure that multiple publications from the same trial were included only once.”
§ Probiotics for treating acute infectious diarrhoea > Methods > Data collection and analysis
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“We attempted to identify all relevant studies regardless of language.”
§ Probiotics for treating acute infectious diarrhoea > Methods > Search methods for identification of studies
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Between‐study heterogeneity may be due to other differences between trials such as the definitions used for “acute diarrhoea” and “the end of the diarrhoeal episode.””
§ Probiotics for treating acute infectious diarrhoea > Discussion > Overall completeness and applicability of evidence
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Differences in causes of diarrhoea likely account for some of the statistical heterogeneity between studies and have likely changed over time, for example, as a result of immunization programmes such as those for rotavirus.”
§ Probiotics for treating acute infectious diarrhoea > Discussion > Overall completeness and applicability of evidence
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Probiotics were not associated with adverse events, but reporting was limited.”
§ Probiotics for treating acute infectious diarrhoea > Discussion > Summary of main results
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The included trials were undertaken in many different countries from different world regions and, therefore, were adequate to address the main research question.”
§ Probiotics for treating acute infectious diarrhoea > Discussion > Overall completeness and applicability of evidence
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“However, a recent review found no evidence that the source of funding for trials of probiotics in diarrhoea had affected trial results (Saa 2019).”
§ Probiotics for treating acute infectious diarrhoea > Discussion > Overall completeness and applicability of evidence
What the sources say
- Not checked — no full text of the sourcecites Saa 2019 source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Probiotics did not prevent hospitalization with acute diarrhoea, with consistency in study findings.”
§ Probiotics for treating acute infectious diarrhoea > Discussion > Summary of main results
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Similarly, marked statistical heterogeneity in the duration of diarrhoea was reported in another recent review of L rhamnosus GG in paediatric diarrhoea (Li 2019).”
§ Probiotics for treating acute infectious diarrhoea > Discussion > Agreements and disagreements with other studies or reviews
What the sources say
- Not matchedcites Li 2019
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
- Not matched
None of the sources cited for this claim could be matched to a paper in Crossref, so there is nothing to check it against.
In the paper
“Correspondence following this review highlighted that the effect of the probiotic was not statistically significant when analysis was limited to studies at low risk of bias (Schnadower 2019b), and that marked heterogeneity persisted in these analyses (Szajewska 2019b).”
§ Probiotics for treating acute infectious diarrhoea > Discussion > Agreements and disagreements with other studies or reviews
What the sources say
- Not matchedcites Schnadower 2019b
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites Szajewska 2019b
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Not matched
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Marked variability in study design likely contributed to the high level of statistical heterogeneity.”
§ Probiotics for treating acute infectious diarrhoea > Authors' conclusions
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. The paper may give no reason why it holds.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Conflicting heterogeneity estimates for L reuteri trials
MajorThe abstract reports I2 = 0% for six L reuteri trials with 433 participants, but the results report I2 = 48% for six trials with the same participant count.
“In six trials (433 participants) of Lactobacillus reuteri, there was consistency amongst findings (I² = 0%)”
“6 studies/433 participants; MD 22.8 hours, 95% CI 13.7 to 32.0; I² = 48%”
Conflicting results for hospitalization in community studies
MajorThe abstract gives six studies, 2283 participants, and RR 1.26, while the results give seven trials, 2333 participants, and RR 1.21 for the same outcome. The text does not identify these as different analyses.
“risk of hospitalization in community studies (RR 1.26, 95% CI 0.84 to 1.89; 6 studies, 2283 participants)”
“In seven trials (2333 participants) of acute diarrhoea in the community, probiotics did not reduce the risk of hospitalization (RR 1.21, 95% CI 0.86 to 1.69)”
Conflicting heterogeneity estimates for hospitalization duration
MinorFor the same 24 inpatient trials and 4056 participants, the abstract reports I2 = 96%, whereas the results report I2 = 95%.
“I² = 96%; MD ‐18.03 hours, 95% CI ‐27.28 to ‐8.78, random‐effects model: 24 trials, 4056 participants”
“In 24 inpatient trials (4056 participants), duration of hospitalization was reduced in the probiotic arm (MD 18.0 hours, 95% CI 8.8 to 27.3) but with marked statistical heterogeneity (I² = 95%”
Adult risk ratio is described as a smaller reduction
MinorThe adult subgroup RR of 0.62 represents a greater relative reduction than the main-analysis RR of 0.64, not a reduction "to a lesser degree."
“probiotics reduced the RR of diarrhoea lasting ≥ 48 hours to a lesser degree than in the main analysis but with consistency between studies (RR 0.62, 95% CI 0.54 to 0.71”
“The risk of diarrhoea lasting ≥ 48 hours was reduced in people receiving a probiotic compared with controls (36 trials/6053 participants; risk ratio (RR) 0.64, 95% confidence interval (CI) 0.52 to 0.79”
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
Cites a retracted work: 10.1002/14651858.cd001264
MajorThe cited work was retracted on 1998-10-26 (notice 10.1002/14651858.cd001264.pub2), before this paper was published (2020-12-08). Its authors could have known.
Cited work 10.1002/14651858.cd001264 · retracted 1998-10-26 · notice 10.1002/14651858.cd001264.pub2 · this paper published 2020-12-08
Citations
Cites
1 retracted
Rice-based oral rehydration solution for treating diarrhoea
Fontaine, O., Gore, S., & Pierce, N. (1998) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001264 · Cited by 79
RetractedHill (2014) · doi:10.1038/nrgastro.2014.66 · Cited by 9,592
Kotloff, K. L., Nataro, J. P., Blackwelder, W. C., Nasrin, D., Farag, T. H., Panchalingam, S., Wu, Y., Sow, S. O., Sur, D., Breiman, R. F., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60844-2 · Cited by 3,560
Liu, L., Oza, S., Hogan, D., Chu, Y., Perin, J., Zhu, J., Lawn, J. E., Cousens, S., Mathers, C., & Black, R. E. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31593-8 · Cited by 3,453
The world health report 2001 - Mental health: new understanding, new hope
Sayers, J. (2001) · Europe PMC (PubMed Central) · doi:10.1590/s0042-96862001001100014 · Cited by 3,307
Liu, L., Oza, S., Hogan, D., Perin, J., Rudan, I., Lawn, J. E., Cousens, S., Mathers, C., & Black, R. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61698-6 · Cited by 3,167
GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology
Guyatt, G. H., Oxman, A. D., Schünemann, H. J., Tugwell, P., & Knottnerus, A. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.09.011 · Cited by 3,094
Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies
Higgins, J. P. T., Jackson, D., Barrett, J. K., Lu, G., Ades, A. E., & White, I. R. (2012) · Research Synthesis Methods · doi:10.1002/jrsm.1044 · Cited by 2,098
Besselink, M. G., van Santvoort, H. C., Buskens, E., Boermeester, M. A., van Goor, H., Timmerman, H. M., Nieuwenhuijs, V. B., Bollen, T. L., van Ramshorst, B., Witteman, B. J., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60207-x · Cited by 1,367
Doron, S., & Snydman, D. R. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ085 · Cited by 942
Guarino, A., Ashkenazi, S., Gendrel, D., Lo Vecchio, A., Shamir, R., & Szajewska, H. (2014) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000375 · Cited by 935
Liu, J., Platts-Mills, J. A., Juma, J., Kabir, F., Nkeze, J., Okoi, C., Operario, D. J., Uddin, M. J., Ahmed, S., Alonso, P. L., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31529-x · Cited by 869
Kaila, M., Isolauri, E., Soppi, E. T., Virtanen, E., Laine, S., & Arvilommi, H. S. (1992) · Pediatric Research · doi:10.1203/00006450-199208000-00002 · Cited by 700
Isolauri, E., Juntunen, M., Rautanen, T., Sillanaukee, P., & Koivula, T. (1991) · PubMed · Cited by 684
Guandalini, S., Pensabene, L., Zikri, M. A., Dias, J. A., Casali, L. G., Hoekstra, H., Kolaček, S., Massar, K., Mičetić‐Turk, D., Papadopoulou, A., et al. (2000) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200001000-00018 · Cited by 659
Probiotics for treating acute infectious diarrhoea
Allen, S. J., Martinez, E. G., Gregorio, G. V., & Dans, L. F. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003048.pub3 · Cited by 628
Self-citationLactic Acid Bacteria in the Treatment of Acute Rotavirus Gastroenteritis
Majamaa, H., Isolauri, E., Saxelin, M., & Vesikari, T. (1995) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-199504000-00012 · Cited by 551
Williams, N. T. (2010) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp090168 · Cited by 522
Diarrhea incidence in low- and middle-income countries in 1990 and 2010: a systematic review
Fischer Walker, C. L., Perin, J., Aryee, M. J., Boschi-Pinto, C., & Black, R. E. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-220 · Cited by 471
Su, G. L., Ko, C. W., Bercik, P., Falck-Ytter, Y., Sultan, S., Weizman, A. V., & Morgan, R. L. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.05.059 · Cited by 421
World Gastroenterology Organisation Global Guidelines: Probiotics and Prebiotics October 2011
Guarner, F., Khan, A. G., Garisch, J., Eliakim, R., Gangl, A., Thomson, A., Krabshuis, J., Lemair, T., Kaufmann, P., de Paula, J. A., et al. (2012) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3182549092 · Cited by 418
Oral zinc for treating diarrhoea in children
Lazzerini, M., & Wanzira, H. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005436.pub5 · Cited by 415
Probiotics for treating infectious diarrhoea
Allen, S. J., Okoko, B. J., Martinez, E. G., Gregorio, G. V., & Dans, L. F. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003048.pub2 · Cited by 408
Self-citationLactobacillus reuteri as a Therapeutic Agent in Acute Diarrhea in Young Children
Shornikova, A., Casas, I. A., Isolauri, E., Mykkänen, H. M., & Vesikari, T. (1997) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-199704000-00008 · Cited by 394
Likelihood of Null Effects of Large NHLBI Clinical Trials Has Increased over Time
Kaplan, R. M., & Irvin, V. L. (2015) · PLOS ONE · doi:10.1371/journal.pone.0132382 · Cited by 356
Probiotics for Prevention and Treatment of Diarrhea
Guandalini, S. (2011) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3182257e98 · Cited by 351
Canani, R. B., Cirillo, P., Terrin, G., Cesarano, L., Spagnuolo, M. I., Vincenzo, A. D., Albano, F., Passariello, A., Marco, G. D., Manguso, F., et al. (2007) · BMJ · doi:10.1136/bmj.39272.581736.55 · Cited by 328
Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis
Shornikova, A., Casas, I. A., Mykkänen, H. M., Salo, E., & Vesikari, T. (1997) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199712000-00002 · Cited by 319
The Lactobacillus casei group: history and health related applications
Hill, D., Sugrue, I., Tobin, C., Hill, C., Stanton, C., & Ross, R. P. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02107 · Cited by 318
Yelin, I., Flett, K. B., Merakou, C., Mehrotra, P., Stam, J., Snesrud, E., Hinkle, M., Lesho, E., McGann, P., McAdam, A. J., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0626-9 · Cited by 315
Guarino, A., Canani, R. B., Spagnuolo, M. I., Albano, F., & Benedetto, L. D. (1997) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-199711000-00005 · Cited by 294
Viable versus inactivated lactobacillus strain GG in acute rotavirus diarrhoea.
Kaila, M., Isolauri, E., Saxelin, M., Arvilommi, H. S., & Vesikari, T. (1995) · Archives of Disease in Childhood · doi:10.1136/adc.72.1.51 · Cited by 287
Rijkers, G. T., Bengmark, S., Enck, P., Haller, D., Herz, U., Kalliomaki, M., Kudo, S., Lenoir-Wijnkoop, I., Mercenier, A., Myllyluoma, E., et al. (2010) · The Journal of Nutrition · doi:10.3945/jn.109.113779 · Cited by 271
Oral bacteriotherapy for viral gastroenteritis
Isolauri, E., Kaila, M., Mykkänen, H. M., Ling, W. H., & Salminen, S. (1994) · Digestive Diseases and Sciences · doi:10.1007/bf02087695 · Cited by 269
Wolvers, D., Antoine, J.-M., Myllyluoma, E., Schrezenmeir, J., Szajewska, H., & Rijkers, G. T. (2010) · The Journal of Nutrition · doi:10.3945/jn.109.113753 · Cited by 268
Choosing an appropriate probiotic product for your patient: An evidence-based practical guide
Sniffen, J. C., McFarland, L. V., Evans, C. T., & Goldstein, E. J. C. (2018) · PLOS ONE · doi:10.1371/journal.pone.0209205 · Cited by 265
Kotloff, K. L., Nasrin, D., Blackwelder, W. C., Wu, Y., Farag, T. H., Panchalingam, S., Sow, S. O., Sur, D., Zaidi, A. K. M., Faruque, A. S. G., et al. (2019) · The Lancet Global Health · doi:10.1016/s2214-109x(19)30076-2 · Cited by 249
Multicenter Trial of a Combination Probiotic for Children with Gastroenteritis
Freedman, S. B., Williamson-Urquhart, S., Farion, K. J., Gouin, S., Willan, A. R., Poonai, N., Hurley, K. F., Sherman, P. M., Finkelstein, Y., Lee, B. E., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1802597 · Cited by 243
Safety of probiotics used to reduce risk and prevent or treat disease.
(2011) · PubMed Central · Cited by 242
Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescents
Fedorowicz, Z., Jagannath, V. A., & Carter, B. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005506.pub5 · Cited by 236
Probiotics for Prevention and Treatment of Diarrhea
Guarino, A., Guandalini, S., & Vecchio, A. L. (2015) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000349 · Cited by 217
Oral versus intravenous rehydration for treating dehydration due to gastroenteritis in children
Hartling, L., Bellemare, S., Wiebe, N., Russell, K. F., Klassen, T. P., & Craig, W. R. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004390.pub2 · Cited by 210
Lactobacillus rhamnosus GG versus Placebo for Acute Gastroenteritis in Children
Schnadower, D., Tarr, P. I., Casper, T. C., Gorelick, M. H., Dean, J. M., O’Connell, K. J., Mahajan, P., Levine, A. C., Bhatt, S. R., Roskind, C. G., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1802598 · Cited by 208
Effect of probiotic Lactobacillus strains in young children hospitalized with acute diarrhea
Rosenfeldt, V., Michaelsen, K. F., Jakobsen, M., Larsen, C. N., Møller, P. L., Pedersen, P., Tvede, M., WEYREHTER, H., Valerius, N. H., & Pærregaard, A. (2002) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200205000-00012 · Cited by 207
Grandy, G., Medina, M., Soria, R., Terán, C. G., & Araya, M. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-253 · Cited by 203
Henker, J., Laass, M. W., Blokhin, B. M., Bolbot, Y. K., Maydannik, V. G., Elze, M., Wolff, C., & Schulze, J. (2007) · European Journal of Pediatrics · doi:10.1007/s00431-007-0419-x · Cited by 199
Lactobacillus GG promotes recovery from acute nonbloody diarrhea in Pakistan
RAZA, S., Graham, S. M., Allen, S. J., Sultana, S., Cuevas, L. E., & Hart, C. A. (1995) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199502000-00005 · Cited by 195
Self-citationWunderlich, P. F., Braun, L., Fumagalli, I. A. L., D’Apuzzo, V., Heim, F., Karly, M., Lodi, R., Politta, G., Vonbank, F., & Zeltner, L. (1989) · Journal of International Medical Research · doi:10.1177/030006058901700405 · Cited by 177
Rosenfeldt, V., Michaelsen, K. F., Jakobsen, M., Larsen, C. N., Møller, P. L., Tvede, M., WEYREHTER, H., Valerius, N. H., & Pærregaard, A. (2002) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200205000-00013 · Cited by 164
Shornikova, A., Isolauri, E., Burkanova, L., Lukovnikova, S., & Vesikari, T. (1997) · Acta Paediatrica · doi:10.1111/j.1651-2227.1997.tb08913.x · Cited by 164
Bafeta, A., Koh, M., Riveros, C., & Ravaud, P. (2018) · Annals of Internal Medicine · doi:10.7326/m18-0343 · Cited by 162
Pedone, C., Arnaud, C., Postaire, E., Bouley, C., & Reinert, P. (2000) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2000.tb10929.x · Cited by 159
Antivirulence Properties of Probiotics in Combating Microbial Pathogenesis
Nair, M. S., Amalaradjou, M. A. R., & Venkitanarayanan, K. (2017) · Advances in applied microbiology · doi:10.1016/bs.aambs.2016.12.001 · Cited by 157
Sindhu, K. N., Sowmyanarayanan, T. V., Paul, A., Babji, S., Ajjampur, S. S. R., Priyadarshini, S. J., Sarkar, R., Balasubramanian, K. A., WANKE, C. A., Ward, H., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu065 · Cited by 155
Effects of Saccharomyces boulardii in children with acute diarrhoea
Kurugöl, Z., & Koturoğlu, G. (2005) · Acta Paediatrica · doi:10.1111/j.1651-2227.2005.tb01786.x · Cited by 150
Sarker, S. A., Sultana, S., Fuchs, G. J., Alam, N. H., Azim, T., Brüssow, H., & Hammarström, L. L. G. (2005) · PEDIATRICS · doi:10.1542/peds.2004-2334 · Cited by 146
Pedone, C., Bernabeu, A. S., Postaire, E., Bouley, C., & Reinert, P. (1999) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1999.tb11698.x · Cited by 142
Szymański, H., Pejcz, J., Jawień, M., Chmielarczyk, A., Strus, M., & Heczko, P. B. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02740.x · Cited by 141
Lactobacillus GG and acute diarrhoea in young children in the tropics
Pant, A. (1996) · Journal of Tropical Pediatrics · doi:10.1093/tropej/42.3.162 · Cited by 138
Role of a probiotic (Saccharomyces boulardii) in management and prevention of diarrhoea
Billoo, A. G. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i28.4557 · Cited by 136
Pozo-Olano, J. D. D., Warram, J. H., Gómez, R. G., & Cavazos, M. G. (1978) · PubMed · Cited by 135
Simakachorn, N., Pichaipat, V., Rithipornpaisarn, P., Kongkaew, C., Tongpradit, P., & Varavithya, W. (2000) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200001000-00020 · Cited by 130
Terán, C. G., Teran-Escalera, C. N., & Villarroel, P. (2008) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2008.09.014 · Cited by 125
Salazar‐Lindo, E., Miranda-Langschwager, P., Campos, M. A. L., Chea-Woo, E., & Sack, R. B. (2004) · BMC Pediatrics · doi:10.1186/1471-2431-4-18 · Cited by 125
Probiotic mechanisms of action
Halloran, K., & Underwood, M. A. (2019) · Early Human Development · doi:10.1016/j.earlhumdev.2019.05.010 · Cited by 123
Probiotics Have Clinical, Microbiologic, and Immunologic Efficacy in Acute Infectious Diarrhea
Chen, C., Kong, M., Lai, M., Chao, H., Chang, K.-W., Chen, S.-Y., Huang, Y.-C., Chiu, C., Li, W.-C., Lin, P.-Y., et al. (2010) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181b530bf · Cited by 120
Szajewska, H., Kołodziej, M., Gieruszczak‐Białek, D., Skórka, A., Ruszczyński, M., & Shamir, R. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15267 · Cited by 120
Limitations of Probiotic Therapy in Acute, Severe Dehydrating Diarrhea
Costa‐Ribeiro, H., Ribeiro, T. C. M., de Mattos, Â. P., Valois, S., Neri, D. A., Almeida, P., Cerqueira, C. M., Ramos, E., Young, R. J., & Vanderhoof, J. A. (2003) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200301000-00021 · Cited by 119
Recommendations for Probiotic Use—2015 Update: Proceedings and Consensus Opinion
Floch, M. H., Walker, W. A., Sanders, M. E., Nieuwdorp, M., Kim, A. S., Brenner, D. A., Qamar, A. A., Miloh, T. A., Guarino, A., Guslandi, M., et al. (2015) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000420 · Cited by 119
Francavilla, R., Lionetti, E., Castellaneta, S. P., Ciruzzi, F., Indrio, F., Masciale, A., Fontana, C. R., Rosa, M. M. L., Cavallo, L., & Francavilla, A. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05180.x · Cited by 113
Global burden of childhood diarrhea and interventions
Das, J. K., Salam, R. A., & Bhutta, Z. A. (2014) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000096 · Cited by 112
Basu, S., Paul, D. K., Ganguly, S., Chatterjee, M., & Chandra, P. K. (2009) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31815a5780 · Cited by 111
Agarwal, K., & Bhasin, S. (2002) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601664 · Cited by 108
Universal recommendations for the management of acute diarrhea in nonmalnourished children
Guarino, A., Lo Vecchio, A., Dias, J. A., Berkley, J. A., Boey, C., Bruzzese, D., Cohen, M. B., Cruchet, S., Liguoro, I., Salazar‐Lindo, E., et al. (2018) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000002053 · Cited by 108
Saccharomyces boulardii in acute childhood diarrhoea: a randomized, placebo‐controlled study
Villarruel, G., Rubio, D. M., López, F. G. B., Cintioni, J., Gurevech, R., Romero, G. G., & Vandenplas, Y. (2007) · Acta Paediatrica · doi:10.1111/j.1651-2227.2007.00191.x · Cited by 106
Effect of a lactobacilli preparation on traveler's diarrhea
Pozo-Olano, J. D. D., Warram, J. H., Gómez, R. G., & Cavazos, M. G. (1978) · Gastroenterology · doi:10.1016/0016-5085(78)90135-x · Cited by 105
Controlled trial of orally administered lactobacilli in acute infantile diarrhea
Pearce, J., & Hamilton, J. R. (1974) · The Journal of Pediatrics · doi:10.1016/s0022-3476(74)80618-9 · Cited by 103
Henker, J., Laass, M. W., Blokhin, B. M., Maydannik, V. G., Bolbot, Y. K., Elze, M., Wolff, C., Schreiner, A., & Schulze, J. (2008) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318169034c · Cited by 100
Lei, V., Friis, H., & Michaelsen, K. F. (2006) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2006.04.022 · Cited by 97
Pathogens That Cause Travelers' Diarrhea in Latin America and Africa
Black, R. E. (1986) · Clinical Infectious Diseases · doi:10.1093/clinids/8.supplement_2.s131 · Cited by 97
Fang, S., Lee, H., Hu, J. J., Hou, S., Liu, H.-L., & Fang, H.-W. (2009) · Journal of Tropical Pediatrics · doi:10.1093/tropej/fmp001 · Cited by 94
Htwe, K., Yee, K. S., Tin, M., & Vandenplas, Y. (2008) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2008.78.214 · Cited by 93
Bellomo, G., Mangigle, A., Nicastro, L., & Frigerio, G. (1980) · Cited by 92
Systematic review of probiotics for the treatment of community-acquired acute diarrhea in children
Applegate, J. A., Fischer Walker, C. L., Ambikapathi, R., & Black, R. E. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-s3-s16 · Cited by 87
Florez, I. D., Veroniki, A.-A., Al Khalifah, R., Yepes-Nuñez, J. J., Sierra, J. M., Vernooij, R. W. M., Acosta-Reyes, J., Granados, C. M., Pérez-Gaxiola, G., Cuello-Garcia, C., et al. (2018) · PLOS ONE · doi:10.1371/journal.pone.0207701 · Cited by 87
Persistent diarrhoea in children in developing countries: memorandum from a WHO meeting.
(1988) · PubMed · Cited by 86
Moal, V. L.-L., Sarrazin-Davila, L. E., & Servin, A. L. (2007) · PEDIATRICS · doi:10.1542/peds.2006-2930 · Cited by 85
Efficacy of SF 68 in the Treatment of Acute Diarrhea a Placebo-Controlled Trial
Buydens, P., & Debeuckelaere, S. (1996) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529609051997 · Cited by 84
Lin, J.-S., Chiu, Y., Lin, N.-T., Chu, C.-H., Huang, K., Liao, K., & Peng, K. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.11.114 · Cited by 84
Ahmadi, E., Alizadeh‐Navaei, R., & Rezai, M. S. (2015) · PubMed · Cited by 82
Basu, S., Chatterjee, M., Ganguly, S., & Chandra, P. K. (2007) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.2007.01201.x · Cited by 79
Effect of Feeding Yogurt Versus Milk in Children With Acute Diarrhea and Carbohydrate Malabsorption
Boudraa, G., Benbouabdellah, M., Hachelaf, W., Boisset, M., Desjeux, J., & Touhami, M. (2001) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200109000-00015 · Cited by 79
Salari (2012) · doi:10.2174/187152812798889394 · Cited by 78
Probiotics and prebiotics in clinical tests: an update
Brüssow, H. (2019) · F1000Research · doi:10.12688/f1000research.19043.1 · Cited by 78
Polymer-based oral rehydration solution for treating acute watery diarrhoea
Gregorio, G. V., Gonzales, M. L. M., Dans, L. F., & Martinez, E. G. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006519.pub3 · Cited by 77
Self-citationLi, Y.-T., Xu, H., Ye, J.-Z., Wu, W.-R., Shi, D., Fang, D.-Q., Liu, Y., & Li, L.-J. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i33.4999 · Cited by 77
Mitra, A. K., & Rabbani, G. H. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90638-h · Cited by 76
Dinleyici, E. Ç., PROBAGE Study Group, & Vandenplas, Y. (2014) · Acta Paediatrica · doi:10.1111/apa.12617 · Cited by 76
North American Congress of Clinical Toxicology (NACCT) Abstracts 2018
(2018) · Clinical Toxicology · doi:10.1080/15563650.2018.1506610 · Cited by 76
Lactobacillus reuteri DSM 17938 shortens acute infectious diarrhea in a pediatric outpatient setting
Dinleyici, E. Ç., Dalgıç, N., Güven, Ş., Akcan, Ö. M., Yasa, O., Kurugöl, Z., Türel, Ö., Tanır, G., Yazar, A. S., Arıca, V., et al. (2015) · Jornal de Pediatria · doi:10.1016/j.jped.2014.10.009 · Cited by 75
The Comparition of the Efficacy of Two Different Probiotics in Rotavirus Gastroenteritis in Children
Erdoğan, Ö., Tanyeri, B., Torun, E., Gönüllü, E., Arslan, H., Erenberk, U., & Öktem, F. (2012) · Journal of Tropical Medicine · doi:10.1155/2012/787240 · Cited by 74
Rautanen, T., Isolauri, E., Salo, E., & Vesikari, T. (1998) · Archives of Disease in Childhood · doi:10.1136/adc.79.2.157 · Cited by 73
Use of VSL♯3 in the Treatment of Rotavirus Diarrhea in Children
Dubey, A. P., Rajeshwari, K., Chakravarty, A., & Famularo, G. (2008) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31816fc2f6 · Cited by 72
Park, M., Kwon, B., Ku, S., & Ji, G. (2017) · Nutrients · doi:10.3390/nu9080887 · Cited by 71
The Effects of Bifidobacterium breve Administration on Campylobacter Enteritis
Tojo, M., Oikawa, T., Morikawa, Y., Yamashita, N., Iwata, S., Satoh, Y., Hanada, J., & Tanaka, R. (1987) · Pediatrics International · doi:10.1111/j.1442-200x.1987.tb00024.x · Cited by 70
[Efficacy of Saccharomyces boulardii in the treatment of diarrhea in AIDS].
Saint-Marc, T., Rossello-Prats, L., & Jl, T. (1991) · PubMed · Cited by 70
BECK, C., & NECHELES, H. (1961) · PubMed · Cited by 69
Current concepts in the evaluation, diagnosis and management of acute infectious diarrhea
Gadewar, S., & Fasano, A. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.08.002 · Cited by 67
Probiotic, zinc and lactose‐free formula in children with rotavirus diarrhea: Are they effective?
Dalgıç, N., Sancar, M., Bayraktar, B., Pullu, M., & Haşim, Ö. (2011) · Pediatrics International · doi:10.1111/j.1442-200x.2011.03325.x · Cited by 63
[Treatment of acute infantile diarrhea: controlled trial of Saccharomyces boulardii].
Chapoy, P. R. (1985) · PubMed · Cited by 58
Escribano, J., Ferré, N., Gispert‐Llauradó, M., Luque, V., Rubio-Torrents, C., Zaragoza-Jordana, M., Polanco, I., Codoñer, F. M., Chenoll, E., Morera, M., et al. (2018) · Pediatric Research · doi:10.1038/pr.2018.34 · Cited by 58
Three-Combination Probiotics Therapy in Children With Salmonella and Rotavirus Gastroenteritis
Huang, Y.-F., Liu, P., Chen, Y., et al. (2013) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31828f1c6e · Cited by 57
Aggarwal, S., Upadhyay, A., Shah, D., Teotia, N., Agarwal, A., & Jaiswal, V. K. (2014) · Europe PMC (PubMed Central) · Cited by 56
A Randomized Controlled Trial to Evaluate the Efficacy of Lactobacillus GG in Infantile Diarrhea
Misra, S., Sabui, T. K., & Pal, N. K. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.01.060 · Cited by 56
Effectiveness and Safety of Lactobacillus LB in the Treatment of Mild Acute Diarrhea in Children
Salazar‐Lindo, E., Figueroa‐Quintanilla, D., Caciano, M. I., Reto‐Valiente, V., Chauvière, G., Colin, P., & Lacteol Study Group (2007) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3180375594 · Cited by 56
Schrezenmeir, J., Heller, K. J., McCue, M. J., Llamas, C. V., Lam, W., Burow, H., Kindling-Rohracker, M., Fischer, W., Sengespeik, H. C., Comer, G. M., et al. (2004) · Clinical Pediatrics · doi:10.1177/000992280404300305 · Cited by 56
Treatment of Acute Diarrhea With Saccharomyces boulardii in Infants
Corrêa, N. B. O., Penna, F. J., Lima, F. M. L. S., Nicoli, J. R., & Filho, L. A. P. (2011) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31822b7ab0 · Cited by 55
Oral zinc for treating diarrhoea in children
Lazzerini, M., & Ronfani, L. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005436.pub4 · Cited by 54
Dutta, P., Mitra, U., Dutta, S., Rajendran, K., Saha, T. K., & Chatterjee, M. K. (2011) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2011.02745.x · Cited by 53
The Effect of Lactobacillus GG on Acute Diarrheal Illness in the Pediatric Emergency Department
Nixon, A. F., Cunningham, S. J., Cohen, H. W., & Crain, E. F. (2012) · Pediatric Emergency Care · doi:10.1097/pec.0b013e31826cad9f · Cited by 53
Sudha, M. R., Jayanthi, N., Pandey, D. C., & Verma, A. K. (2019) · Beneficial Microbes · doi:10.3920/bm2018.0094 · Cited by 53
Oral bacterial therapy promotes recovery from acute diarrhea in children.
Lee, M., Lin, L., Hung, K., & Wu, H.-Y. (2001) · PubMed · Cited by 52
Ritchie, B. K., Brewster, D., Tran, C. D., Davidson, G. P., McNeil, Y., & Butler, R. N. (2010) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3181bbf53d · Cited by 52
Glanville, J., King, S., Guarner, F., Hill, C., & Sanders, M. E. (2015) · Nutrition Journal · doi:10.1186/s12937-015-0004-5 · Cited by 51
Bhatnagar, S., Singh, K. D., Sazawal, S., et al. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70398-1 · Cited by 50
Maity, C., & Gupta, A. K. (2018) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-018-2562-x · Cited by 50
Özkan, T., Sahin, E., Erdemır, G., & Budak, F. (2007) · Journal of International Medical Research · doi:10.1177/147323000703500204 · Cited by 49
Patro-Gołąb, B., & Szajewska, H. (2019) · Nutrients · doi:10.3390/nu11112762 · Cited by 49
Narayanappa, D. (2008) · The Indian Journal of Pediatrics · doi:10.1007/s12098-008-0134-2 · Cited by 47
Dinleyici, E. Ç., Kara, A., Dalgıç, N., Kurugöl, Z., Arıca, V., Akcan, Ö. M., Temur, E., Türel, Ö., Güven, Ş., Yasa, O., et al. (2015) · Beneficial Microbes · doi:10.3920/bm2014.0086 · Cited by 47
Das, S., Gupta, P. K., & Das, R. R. (2016) · Journal of Tropical Pediatrics · doi:10.1093/tropej/fmw032 · Cited by 45
Smectite for acute infectious diarrhoea in children
Gaxiola, G. P., Cuello‐García, C. A., Flórez, I. D., & Pérez-Pico, V. M. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011526.pub2 · Cited by 44
Evaluation of yogurt effect on acute diarrhea in 6-24-month-old hospitalized infants
Pashapour, N., & lou, S. G. (2006) · The Turkish Journal of Pediatrics · doi:10.24953/turkjpediatr.2006.2610 · Cited by 44
Szymański, H., & Szajewska, H. (2019) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000002355 · Cited by 44
Riaz, M., Alam, S., Malik, A., & Ali, S. M. (2012) · The Indian Journal of Pediatrics · doi:10.1007/s12098-011-0573-z · Cited by 43
Efficacy of tyndalizedLactobacillus acidophilus in acute diarrhea
Khanna, V., Alam, S., Malik, A., et al. (2005) · The Indian Journal of Pediatrics · doi:10.1007/bf02731667 · Cited by 42
Harris, R. G., Neale, E. P., & Ferreira, I. (2019) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqz071 · Cited by 38
Eren, M., Dinleyici, E. Ç., & Vandenplas, Y. (2010) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2010.09-0529 · Cited by 36
Current calcium recommendations in North America.
Mao, M., Yu, T., Xiong, Y., Wang, Z., Liu, H., Gotteland, M., & Brunser, O. (2008) · PubMed · Cited by 36
Probiotics for treating infectious diarrhoea
Allen, S. J., Okoko, B. J., Martinez, E. G., Gregorio, G. V., & Dans, L. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003048 · Cited by 36
Self-citationA Double-Blind Comparison of Two Different Treatments for Acute Enteritis in Adults
Camarri, E., Belvisi, A., Guidoni, G., et al. (2009) · Chemotherapy · doi:10.1159/000238017 · Cited by 35
Chandra, R. K. (2002) · Nutrition Research · doi:10.1016/s0271-5317(01)00367-0 · Cited by 34
Chau, T. T. H., Chau, N. N. M., Nhat, L. T. H., The, H. C., Vinh, P. V., To, N. T. N., Ngọc, N. M., Tuấn, H. M., Ngoc, T. L. C., Kolader, M.-E., et al. (2017) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001712 · Cited by 33
Maragkoudaki, M., Chouliaras, G., Moutafi, A. C., Thomas, A., Orfanakou, A., & Papadopoulou, A. (2018) · Nutrients · doi:10.3390/nu10091189 · Cited by 33
El-Soud, N. H. A., Said, R. N., Mosallam, D., Barakat, N. A. M., & Sabry, M. A. (2015) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2015.088 · Cited by 32
Yogurt in the Treatment of Infantile Diarrhea
Niv, M., Levy, W., & GREENSTEIN, N. M. (1963) · Clinical Pediatrics · doi:10.1177/000992286300200710 · Cited by 32
The Role of Probiotics in the Treatment of Dysentery: a Randomized Double-Blind Clinical Trial
Sharif, A., Kashani, H. H., Nasri, E., Soleimani, Z., & Sharif, M. R. (2017) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-017-9271-0 · Cited by 31
Phavichitr, N., Puwdee, P., & Tantibhaedhyangkul, R. (2013) · PubMed · Cited by 30
Walker-Smith, J. A. (1993) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(93)90530-4 · Cited by 29
Rerksuppaphol, S., & Rerksuppaphol, L. (2010) · Annals of Tropical Paediatrics · doi:10.1179/146532810x12858955921159 · Cited by 29
Pernica, J. M., Steenhoff, A. P., Mokomane, M., Moorad, B., Lechiile, K., Smieja, M., Mazhani, L., Cheng, J., Kelly, M. S., Loeb, M. B., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185177 · Cited by 29
Lactobacillus casei in the control of acute diarrhea--a pilot study.
Agarwal, K. N., Bhasin, S. K., Faridi, M., Mathur, M., & Gupta, S. (2001) · PubMed · Cited by 28
Epidemiology of diarrhoeal diseases in developed countries
Savarino, S. J., & Bourgeois, A. L. (1993) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(93)90529-y · Cited by 28
Hegar, B., Waspada, I. M. I., Gunardi, H., & Vandenplas, Y. (2014) · The Indian Journal of Pediatrics · doi:10.1007/s12098-014-1408-5 · Cited by 27
Heydarian, F., Kianifar, H. R., Ahanchian, H., Khakshure, A., Seyedi, J., & Moshirian, D. (2010) · Saudi Medical Journal · doi:10.15537/1658-3175.4977 · Cited by 26
Mao, M., Yu, T., Xiong, Y., Wang, Z., Liu, H., Gotteland, M., & Brunser, O. (2008) · Universidad de Chile · Cited by 26
Probiotics in the Treatment of Acute Diarrhea in Young Children
Moghiman, T., Jabbari, F., Ahanchian, H., Farid, R., Kianifar, H. R., & Sistanian, A. (2009) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 23
Margreiter, M., Ludl, K., Phleps, W., et al. (2006) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp44207 · Cited by 22
[The efficacy of the new bacterial preparation biosporin in treating acute intestinal infections].
Михайловна, Г. Н., Gavrilov, A. F., Solov'eva, A. I., Vv, S., Sorokulova, I. B., Reznik, S. R., & Nv, C. (1996) · PubMed · Cited by 21
Luyer, B. L., Makhoul, G., & Duhamel, J.-F. (2010) · Archives de Pédiatrie · doi:10.1016/j.arcped.2010.02.004 · Cited by 20
Efficacy of probiotics in acute diarrhoea in children
Bhat, S., Shreekrishna, G. N., & Savio, C. (2018) · International Journal of Contemporary Pediatrics · doi:10.18203/2349-3291.ijcp20182582 · Cited by 20
Efficacy and safety of Saccharomyces boulardii in amebiasis-associated diarrhea in children
Erdeve, Ş. S., Gökay, S., & Dallar, Y. B. (2009) · The Turkish Journal of Pediatrics · doi:10.24953/turkjpediatr.2009.2291 · Cited by 19
Comparison of three probiotics in the treatment of acute diarrhea in mentally retarded children.
Barone, C., Pettinato, R., Avola, E., Alberti, A., Greco, D., Failla, P., & Romano, C. (2000) · PubMed · Cited by 18
Freedman, S. B., Sherman, P. M., Willan, A., Johnson, D., Gouin, S., Schuh, S., & (PERC), O. B. O. P. E. R. C. (2015) · Clinical Pediatrics · doi:10.1177/0009922815569200 · Cited by 16
Bruno, F., & Frigerio, G. (1981) · PubMed · Cited by 16
[Clinical assessment of a new oral bacterial treatment for children with acute diarrhea].
Michielutti, F., Bertini, M., Presciuttini, B., et al. (1996) · PubMed · Cited by 16
Asmat, S., Shaukat, F., Asmat, R., et al. (2018) · Journal of College of Physicians And Surgeons Pakistan · doi:10.29271/jcpsp.2018.03.214 · Cited by 16
Vivatvakin, B., & Kowitdamrong, E. (2006) · PubMed · Cited by 15
Padayachee, M., Visser, J., Viljoen, E., Musekiwa, A., & Blaauw, R. (2019) · South African Journal of Clinical Nutrition · doi:10.1080/16070658.2018.1449378 · Cited by 15
Burande, M. A. (2013) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.114603 · Cited by 14
Management of infant diarrhea with high-lactose probiotic-containing formula.
Sudarmo, S. M., Ranuh, R. G., ., A. R., & Soeparto, P. (2003) · PubMed · Cited by 14
Lactobacillus acidophilus yogurt and supplement in children with acute diarrhea: A clinical trial
Rafeey, M., Ostadrahimi, A., Boniadi, M., Ghorashi, Z., Alizadeh, M., & Hadafey (2008) · Cited by 14
Rice-based oral rehydration solution for treating diarrhoea
Fontaine, O., Gore, S. M., & Pierce, N. F. (1998) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001264.pub2 · Cited by 13
Pène, P., Linhard, J., & Jc, B. (1966) · PubMed · Cited by 12
[Use of lactic enzymes in non-bacterial gastroenteritis].
Chicoine, L., & Joncas, J. H. (1973) · PubMed · Cited by 12
Bacillus Clausii As An Adjuvant Therapy In Acute Childhood Diarrhoea
Journals, I., Lahiri, K. R., Jadhav, K., et al. (2015) · Figshare · doi:10.6084/m9.figshare.1421572 · Cited by 12
Schnadower, D., Tarr, P. I., & Freedman, S. B. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15418 · Cited by 11
Bruno, F., Nastasi, A., & Bruno, M. (1983) · PubMed · Cited by 10
Efficacy of Probiotic Saccharomyces boulardii as an Adjuvant Therapy in Acute Childhood Diarrhoea
Dash, D. K., Dash, M., Mohanty, M. D., et al. (2017) · Journal of Nepal Paediatric Society · doi:10.3126/jnps.v36i3.15539 · Cited by 10
Vidjeadevan, D., Vinoth, S., & Ramesh, S. (2018) · International Journal of Contemporary Pediatrics · doi:10.18203/2349-3291.ijcp20183511 · Cited by 10
Saa, C., Bunout, D., & Hirsch, S. (2019) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001322 · Cited by 10
Canani, R. B., Albano, F., Spagnuolo, M. I., et al. (1997) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-199704000-00088 · Cited by 9
Yoghurt feeding during acute diarrhea.
Singh, T. (1987) · PubMed · Cited by 9
Czerwionka‐Szaflarska, M., Murawska, S., & Swincow, G. (2009) · Cited by 9
Xie, Y., Gao, S., Wang, L., et al. (2013) · PubMed · Cited by 8
Lactobacillus casei tablets in the treatment of intestinal infection.
Alexander, J. G. (1971) · PubMed · Cited by 8
Simadibrata, M. (2013) · Journal of Clinical Medicine and Research · doi:10.5897/jcmr12.014 · Cited by 8
Developing a core outcome measurement set for clinical trials in acute diarrhoea
Karaś, J., Ashkenazi, S., Guarino, A., Vecchio, A. L., Shamir, R., Vandenplas, Y., & Szajewska, H. (2016) · Acta Paediatrica · doi:10.1111/apa.13349 · Cited by 7
[Double-blind study of treatment with SF 68 or with antibiotics in acute enteritis in adults].
Alvisĭ, Tralli, M., Loponte, A., et al. (1982) · PubMed · Cited by 7
D’Apuzzo, V., & Salzberg, R. (1982) · PubMed · Cited by 7
Fourrier, A., & Lequien, P. (1968) · PubMed · Cited by 6
Korviakova, E. P. (2001) · PubMed · Cited by 5
ski, H. S., Pejcz, J., Jawie, M., et al. (2005) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200505000-00123 · Cited by 4
[Randomized comparative testing of a new drug in intestinal disorders in a child].
Ortlieb, R. (1974) · PubMed · Cited by 4
Kasiri, K., Khoshdel, A., Salehi, S., et al. (2018) · International Journal of Pharmaceutical Investigation · doi:10.4103/jphi.jphi_5_19 · Cited by 4
Clinical Efficacy of Bacillus Clausii Probiotic in the Management of Acute Diarrhoea in Children
Hamid, F., Quaium, S. M. M. A., Rahman, A., Hussain, T., & Islam, T. M. T. (2019) · Chattagram Maa-O-Shishu Hospital Medical College Journal · doi:10.3329/cmoshmcj.v18i1.42128 · Cited by 4
P0910 EFFICACY OF PROBIOTIC THERAPY IN ABORIGINAL CHILDREN WITH ACUTE DIARRHEAL DISEASE
Brewster, D., Ritchie, B. K., McNeil, Y., et al. (2004) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200406001-01034 · Cited by 3
Isolauri, E., Rautanen, T., Juntunen, M., et al. (1991) · PEDIATRICS · doi:10.1542/peds.88.1.90 · Cited by 3
Szajewska, H., Kołodziej, M., & Shamir, R. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15431 · Cited by 2
Probiotics for treatment of acute childhood diarrhea
Chen, K. G. (2018) · http://isrctn.com/ · doi:10.1186/isrctn18444252 · Cited by 1
Flagged first, then by citations
Research works printed but not linked: 44
- Azim, 2014, Efficacy of probiotics (Saccharomyces bulardii) in acute watery diarrhoea in children, Journal of Rawalpindi Medical College (JRMC), 18, 213
- Burki, 2017, Efficacy of Saccharomyces boullardii in children with acute diarrhoea, Medical Forum, 28, 112
- Cetina-Sauri, 1994, Evaluation of Saccharomyces boulardii in children with acute diarrhea, Annales de Pediatrie, 41, 397
- D'Apuzzo, 1982, The treatment of acute diarrhoea in paediatrics using Streptococcus faecium: results of a double blind trial, Therapeutische Umschau, 39, 1033
- Hernandez, 1998, Clinical therapeutic effect of Saccharomyces boulardii on children with acute diarrhea, Revista de Enfermedades Infecciosas en Pediatria, 11, 87
- Höchter, 1990, Saccharomyces boulardii in the treatment of acute adult diarrhoea., Münchener Medizinische Wochenschrift, 132, 188
- Jasinski, 2002, Efficacy of Lactobacillus GG in oral rehydration solution, Pediatrika, 22, 231
- Javeed, 2018, Effect of oral Saccharomyces boulardii supplementation on the duration of acute watery diarrhea in children, Pakistan Journal of Medical and Health Sciences, 12, 212
- Khan, 2017, Efficacy of Lactobacillus reuteri in acute watery diarrhea, Medical Forum, 28, 7
- Kowalska-Duplaga, 1999, Lactobif, a marketed probiotic product containing Bifidobacterium ruminantium, was not effective in the treatment of acute rotavirus diarrhoea in infants, Gut, 44, 17
- Kowalska-Duplaga, 2004, Efficacy of Trilac® in the treatment of acute diarrhoea in infants and young children - a multicentre, randomised, double blind placebo-controlled study, Pediatria Wspolczesna, Gastroenterologia, Hepatologia i Zywienie Dziecka, 6, 295
- Sirsat, 2017, Role of Saccharomyces boulardii in management of acute diarrhoea of children - A randomized controlled trial, MedPulse International Journal of Pediatrics, 4, 68
- Urganci, 2001, Evaluation of the efficacy of Saccharomyces boulardii in children with acute diarrhoea, Archives of Gastroenterohepatology, 20, 81
- Ahmadipour, 2018, Probiotic or zinc, which is more effective in treatment of diarrhea in children?, Journal of Pediatric Gastroenterology and Nutrition Conference: 51st Annual Meeting European Society for Paediatric Gastroenterology, Hepatology and Nutrition, 66, 332
- Bellomo, 1979, A new approach for the treatment of enteritides in paediatrics, Médecine et Hygiène, 37, 3781
- Bellomo, 1982, Controlled study of Enterococcus LAB strain SF68 in acute enteritis in children with concomitant respiratory infection, Clinica Pediatrica, 64, 219
- 1995, Controlled clinical trial of Lacteol Fort Sachet versus furazolidone or berberine in treatment of acute diarrhoea in children, Annales de Pediatrie, 42, 396
- Boulloche, 1994, Management of acute diarrhoea in infants and young children. Controlled study of the anti-diarrheal efficacy of killed L. acidophilus (LB strain) versus a placebo and a reference drug (loperamide), Annales de Pediatrie, 41, 457
- Cetina-Sauri, 1990, Therapeutic evaluation of children with acute diarrhea, Tribuna Medica, 81, 141
- Costa-Ribeiro, 2000, Use of Lactobacillus GG in the treatment of severe, acute diarrhoea in adverse environmental conditions, Journal of Pediatric Gastroenterology and Nutrition, 31 Suppl 2, 251
- Costa-Ribeiro, 2000, Prophylactic administration of Lactobacillus GG to children in a daycare center, Journal of Pediatric Gastroenterology and Nutrition, 31 Suppl 2, 252
- 2004, Efficacy of Bacillus coagulans tablets in the treatment of acute and chronic diarrhoea, International Journal of Immunotherapy, 20, 17
- Frigerio, 1986, A lactic acid producer enterococcus in the prevention of antibiotic-associated diarrhoea and in the treatment of acute diarrhoeal disorders: a double-blind multicentre placebo-controlled clinical trial (Abstract), Digestive Diseases and Sciences, 31 Suppl, 496
- Girola, 1995, Efficacy of probiotic preparation with living, freeze-dried lactic acid bacteria and yeast on child diarrhoea, Archivio di Medicina Interna, 47, 61
- Grandy, 2010, Probiotics in the treatment of acute rotavirus diarrhoea. A randomized, double-blind, controlled trial using two different probiotic preparations in Bolivian children, BMC Infectious Diseases, 10, 253, 10.1186/1471-2334-10-253 · DOI
- Hafeez, 2002, The efficacy of Saccharomyces boulardii in the treatment of acute watery diarrhoea in children: a multicentre randomized controlled trial, Journal of College of Physicians and Surgeons Pakistan, 12, 432
- Henker, 2007, Acute diarrhoea in infants and small children. Successful adjuvant therapy with the probiotic Mutaflor, Pädiat. Prax, 71, 605
- Jimenez-Rodriguez C Jimenez-Diaz J Hernandez-Martinez F Rodriguez-De-vera B Efficacy of probiotics against acute diarrhoea in warm areas Annals of Nutrition and Metabolism Conference: 9th workshop probiotics and prebiotics 2018
- Khan, 2012, Clinical efficacy of use of probiotic “Saccharomyces boulardii” in children with acute watery diarrhea, Pakistan Pediatric Journal, 36, 122
- Lahiri, 2015, Beneficial role of probiotic in acute childhood diarrhoea, Journal of Harmonized Research in Medical and Health Science, 2, 26
- Mazo, 2006, Efficacy and safety of milk fermented by lactobacillus (kumis) in nutritional recovery of undernourished children and control of their diarrhoea episodes, Revista Facultad Nacional de Salud Pública, 24, 83
- Moraes, 2001, A multicentric, randomised, investigator-blind, parallel group study to assess the efficacy, safety and tolerability of Racecadotril versus Saccharomyces boulardii in the treatment of acute diarrhoea in adults, Revista Brasileira de Medicina, 58, 65
- Perez, 2019, Coddle study: Bacillus clausii as an adjunctive treatment of acute community-acquired diarrhoea in Filipino children, Journal of Pediatric Gastroenterology and Nutrition, 68, 477
- Satoh, 1984, Effect of Bifidobacterium breve administration on clinical course and intestinal flora in children with acute diarrhea [Abstract], Nippon Shonikagakkai Zasshi, 88, 2178
- Sepp, 1995, Impact of a Lactobacillus probiotic on the faecal microflora in children with shigellosis, Microecology and Therapy, 23, 74
- Simakachorn, 2000, Erratum, Journal of Pediatric Gastroenterology, 30, 228
- Singh, 2018, Comparison of clinical efficacy of Saccharomyces boulardii with yogurt in acute watery diarrhea in children, Pakistan Paediatric Journal, 42, 167
- Sugita, 1994, Efficacy of Lactobacillus preparation bioloactis powder in children with rotavirus enteritis, Japan Journal of Pediatrics, 47, 2755
- Táborská, 1997, Smecta and Lactobacillus acidophilus ND in the treatment of acute diarrhoea in children, Ceskoslovenská Pediatrie, 52, 29
- Zareen, 2018, Effects of probiotics in shortening the duration of acute diarrhea; a randomized control study, Pakistan Journal of Medical and Health Sciences, 12, 471
- Clarke M Oxman A Optimal search strategy. Cochrane Reviewers' Handbook 4.2 [updated March 2003]; Appendix 5c In: The Cochrane Library. The Cochrane Collaboration. Chichester, UK: John Wiley & Sons, Ltd.; 2003, Issue 3
- Schnadower, 2019, Letter: Lactobacillus rhamnosus GG offers no benefit over placebo in children with acute gastroenteritis, Alimentary Pharmacology & Therapeutics, 50, 620, 10.1111/apt.15418 · DOI
- Division of Diarrhoeal and Acute Respiratory Disease Control, 1990, The Treatment of Diarrhoea. A Manual for Physicians and Other Senior Health Workers
- Department of Child and Adolescent Health and Development, 2005, The Treatment of Diarrhoea: A Manual for Physicians and Other Senior Health Workers
Cited by
Sorted by citations
The Potential Impact of Probiotics on Human Health: An Update on Their Health-Promoting Properties
Maftei, N.-M., Raileanu, C. R., Balta, A. A., Ambrose, L., Boev, M., Marin, D. B., & Lisa, E. L. (2024) · Microorganisms · doi:10.3390/microorganisms12020234 · Cited by 381
“However, following a Cochrane analysis of 82 studies that included adults and children, the conclusion was that probiotics still have a low, even uncertain, ability to reduce the duration of acute diarrhea [108].”
BackgroundProbiotics for the Management of Pediatric Gastrointestinal Disorders
Szajewska, H., Canani, R. B., Domellöf, M., Guarino, A., Hojsak, I., Indrio, F., Vecchio, A. L., Mihatsch, W. A., Mosca, A., Orel, R., et al. (2022) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000003633 · Cited by 232
“Since 2019, 4 meta-analyses focusing on the use of probiotics for the treatment of acute infectious diarrhea have been published (17–20).”
World Gastroenterology Organisation Global Guidelines: Probiotics and Prebiotics
Guarner, F., Sanders, M. E., Szajewska, H., Cohen, H., Eliakim, R., Herrera-deGuise, C., Karakan, T., Merenstein, D., Piscoya, A., Ramakrishna, B., et al. (2024) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000002002 · Cited by 209
Involvement of Probiotics and Postbiotics in the Immune System Modulation
Yeşilyurt, N., Yılmaz, B., Ağagündüz, D., & Capasso, R. (2021) · Biologics · doi:10.3390/biologics1020006 · Cited by 222
“The latest Cochrane report states that probiotics are successfully used to prevent infectious diarrhea in both children and adults [138].”
BackgroundMalnutrition and Gut Microbiota in Children
Iddrisu, I., Monteagudo-Mera, A., Poveda, C. G., Pyle, S., Shahzad, M. A., Andrews, S. C., & Walton, G. (2021) · Nutrients · doi:10.3390/nu13082727 · Cited by 186
“Indeed, a recent Cochrane review based on large clinical trials with low risk of bias [51] reported little or no effect of probiotics in the reduction of diarrhoea.”
Background
Metadata
- Authors
- Collinson, S., Deans, A., Padua-Zamora, A., Gregorio, G. V., Li, C., Dans, L. F., & Allen, S. J.
- Affiliations
- Liverpool School of Tropical Medicine (GB)
- Urgent Care; Team Medical; Paraparaumu New Zealand
- Philippine General Hospital (PH)
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2020-12-08
- Volume
- 2020
- Issue
- 12
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- PMC
- PMC8166250
- OpenAlex
- W4211012807
- Semantic Scholar
- f70de0a0060e62224515a25e2e66c788a97b0e88
- Cited by
- 153
- References
- 202
- Citations by year
- 2026: 15 · 2025: 26 · 2024: 37 · 2023: 27 · 2022: 25 · 2021: 19 · 2020: 1
- FWCI
- 10.47
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cochrane Database of Systematic Reviews (publishedVersion)
- LSTM Online Archive (Liverpool School of Tropical Medicine) (acceptedVersion)
- Funders
- London School of Hygiene and Tropical Medicine
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Nursing › Nutrition and Dietetics › Infant Nutrition and Health
- Keywords
- probiotics, acute infectious diarrhea, diarrhea duration, paediatric diarrhoea, hospitalization, adverse events, Lactobacillus, Bifidobacterium, diarrhea treatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-18, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-18 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
